A patient with HF and LVEF > 40%: SGLT2 inhibitors.

27 August 2022 (11:30 - 11:45)
Organised by:
Congress Presentation Part of: How to treat a patient with heart failure and a left ventricular ejection fraction (LVEF) > 40% Treatment ESC Professional Premium Access ESC Congress 2022

ESC 365 is supported by

ESC 365 is supported by